Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition

American Journal of Gastroenterology

Volumn 104, Issue 5, 2009, Pages 1262-1270

  Amiot, Aurelien ^a   Joly, Francisca ^b   Alves, Arnaud ^b   Panis, Yves ^b   Bouhnik, Yoram ^a   Messing, Bernard ^a,b  

^a Hpital Beaujon   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; LAXATIVE; NARCOTIC AGENT; PROKINETIC AGENT; PROTON PUMP INHIBITOR; SPASMOLYTIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC INTESTINAL PSEUDOOBSTRUCTION; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INTESTINE PSEUDOOBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; ONSET AGE; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; SHORT BOWEL SYNDROME; SURVIVAL RATE; SYSTEMIC SCLEROSIS; ABDOMINAL SURGERY; ADOLESCENT; ANALYSIS OF VARIANCE; CAUSE OF DEATH; COHORT ANALYSIS; EVALUATION; GASTROINTESTINAL MOTILITY; HOSPITALIZATION; KAPLAN MEIER METHOD; LONG TERM CARE; MANOMETRY; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CAUSE OF DEATH; COHORT STUDIES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; KAPLAN-MEIERS ESTIMATE; LONG-TERM CARE; MALE; MANOMETRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARENTERAL NUTRITION, HOME; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SHORT BOWEL SYNDROME; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 66949146531     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.58     Document Type: Article

References (64)

1. Rudolph CD, Hyman PE, Altschuler SM et al. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr 1997;24:102-12.
2. De Giorgio R, Sarnelli G, Corinaldesi R et al. Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 2004;53:1549-52.
3. Joly F, Amiot A, Coffin B et al. [Chronic intestinal pseudo-obstruction]. Gastroenterol Clin Biol 2006;30:975-85.
4. Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997;41:675-81.
5. Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology 1999;116:980-7.
6. Knowles CH, Silk DB, Darzi A et al. Deranged smooth muscle alpha-actin as a bio marker of intestinal pseudo-obstruction: a controlled multinational case series. Gut 2004;53:1583-9.
7. Stanghellini V, Camilleri M, Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987;28:5-12.
8. Stanghellini V, Cogliandro RF, De Giorgio R et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol 2005;3:449-58.
9. Streutker CJ, Huizinga JD, Campbell F et al. Loss of CD117 (c-kit)- and CD34-positive ICC and associated CD34-positive fibroblasts defines a subpopulation of chronic intestinal pseudo-obstruction. Am J Surg Pathol 2003;27:228-35.
10. Joly F, Amiot A, Messing B. Chronic intestinal pseudo-obstruction. In Bozzetti F, Staun M, Van Gossum A (eds). Oxford University Press: Oxford, 2007, pp. 84-94.
11. Panganamamula KV, Parkman HP. Chronic intestinal pseudo-obstruction. Curr Treat Options Gastroenterol 2005;8:3-11.
12. Nightingale J, Woodward JM. Guidelines for management of patients with a short bowel. Gut 2006;55 (Suppl 4): ivl-12.
13. Connor FL, Di Lorenzo C. Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology 2006;130:S29-36.
14. Scolapio JS, Ukleja A, Bouras EP et al. Nutritional management of chronic intestinal pseudo-obstruction. J Clin Gastroenterol 1999;28:306-12.
15. Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004;19:687-94.
16. Quigley EM. Chronic intestinal pseudo-obstruction. Curr Treat Options Gastroenterol 1999;2:239-50.
17. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991;325:1461-7.
18. Verne GN, Eaker EY, Hardy E et al. Effect of octreotide and erythromydn on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995;40:1892-901.
19. Kim HY, Kim JH, Jung SE et al. Surgical treatment and prognosis of chronic intestinal pseudo-obstruction in children. J Pediatr Surg 2005;40:1753-9.
20. Pitt HA, Mann LL, Berquist WE et al. Chronic intestinal pseudo-obstruction. Management with total parenteral nutrition and a venting enterostomy. Arch Surg 1985;120:614-8.
21. Faure C, Goulet O, Ategbo S et al. Chronic intestinal pseudoobstruction syndrome: clinical analysis, outcome, and prognosis in 105 children. French-Speaking Group of Pediatric Gastroenterology. Dig Dis Sci 1999;44:953-9.
22. Hanks JB, Meyers WC, Andersen DK et al. Chronic primary intestinal pseudo-obstruction. Surgery 1981;89:175-82.
23. Heneyke S, Smith VV, Spitz L et al. Chronic intestinal pseudo-obstruction: treatment and long term follow up of 44 patients. Arch Dis Child 1999;81:21-7.
24. Mousa H, Hyman PE, Cocjin J et al. Long-term outcome of congenital intestinal pseudoobstruction. Dig Dis Sci 2002;47:2298-305.
25. Scolapio JS, Fleming CR, Kelly DG et al. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin Proc 1999;74:217-22.
26. Vargas JH, Sachs P, Ament ME. Chronic intestinal pseudo-obstruction syndrome in pediatrics. Results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1988;7:323-32.
27. Grant D, Abu-Elmagd K, Reyes J et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg 2005;241:607-13.
28. Abu-Elmagd KM. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology 2006;130:S132-137.
29. Nishida S, Levi DM, Moon JI et al. Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients. Transplant Proc 2006;38:1747-9.
30. Ruiz P, Kato T, Tzakis A. Current status of transplantation of the small intestine. Transplantation 2007;83:1-6.
31. Sauvat F, Dupic L, Caldari D et al. Factors influencing outcome after intestinal transplantation in children. Transplant Proc 2006;38:1689-91.
32. Messing B, Crenn P, Beau P et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999;117:1043-50.
33. Harris JA, Benedict FG. A biometric study of human basal metabolism. Proc Natl Acad Sci USA 1918;4:370-3.
34. Buzby GP, Mullen JL, Matthews DC et al. Prognostic nutritional index in gastrointestinal surgery. Am J Surg 1980;139:160-7.
35. Crenn P, Coudray-Lucas C, Thuillier F et al. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000;119:1496-505.
36. Messing B, Pigot F, Rongier M et al. Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology 1991;100:1502-8.
37. Just B, Messing B, Darmaun D. Oral nutrition in patients receiving home cyclic parenteral nutrition: pattern of substrate utilization. Am J Clin Nutr 1991;54:560-4.
38. Cavicchi M, Beau P, Crenn P et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000;132:525-32.
39. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006;130:S70-77.
40. Nanji AA, Anderson FH. Sensitivity and specificity of liver function tests in the detection of parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 1985;9:307-8.
41. Messing B, Joly F. Guidelines for management of home parenteral support in adult chronic intestinal failure patients. Gastroenterology 2006;130: S43-51.
42. Cosnes J, Lamy P, Beaugerie L et al. Adaptive hyperphagia in patients with postsurgical malabsorption. Gastroenterology 1990;99:1814-9.
43. Crenn P, Morin MC, Joly F et al. Net digestive absorption and adaptive hyperphagia in adult short bowel patients. Gut 2004;53:1279-86.
44. Attar A, Flourie B, Rambaud JC et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 1999;117:794-7.
45. Howard L, Ament M, Fleming CR et al. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 1995;109:355-65.
46. Messing B, Lemann M, Landais P et al. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology 1995;108:1005-10.
47. Howard L. Home parenteral nutrition: survival, cost, and quality of life. Gastroenterology 2006;130:S52-59.
48. Mughal MM, Irving MH. Treatment of end stage chronic intestinal pseudo-obstruction by subtotal enterectomy and home parenteral nutrition. Gut 1988;29:1613-7.
49. Perlemuter G, Cacoub P, Wechsler B et al. [Chronic intestinal pseudo-obstruction secondary to connective tissue diseases]. Gastroenterol Clin Biol 2001;25:251-8.
50. Fautrel B, Aeschlimann A, Bourgeois-Droin C. Sclerodermies. In Kahn MF, Peltier AP, Meyer O et al. (eds). Maladies et syndromes systémiques, 4th edn. Flammarion Medecine-Sdences: Paris, 2000, pp. 469-522.
51. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.
52. Farge D, Passweg J, van Laar JM et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis 2004;63:974-81.
53. Hoyles RK, Ellis RW, Wellsbury J et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006;54:3962-70.
54. Nash RA, McSweeney PA, Crofford LJ et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 2007;110:1388-96.
55. Tashkin DP, Elashoff R, Clements PJ et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-66.
56. Windmueller HG, Spaeth AE. Source and fate of circulating citrulline. Am J Physiol 1981;241:E473-480.
57. Crenn P, Vahedi K, Lavergne-Slove A et al. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003;124:1210-9.
58. Papadia C, Sherwood RA, Kalantzis C et al. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol 2007;102:1474-82.
59. Bines J, Francis D, Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 1998;26:123-8.
60. Dibaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 2006;4:11-20.
61. Rossi TM, Lee PC, Young C et al. Small intestinal mucosa changes, including epithelial cell proliferative activity, of children receiving total parenteral nutrition (TPN). Dig Dis Sci 1993;38:1608-13.
62. Selvaggi G, Gaynor JJ, Moon J et al. Analysis of acute cellular rejection episodes in recipients of primary intestinal transplantation: a single center, 11-year experience. Am J Transplant 2007;7:1249-57.
63. Lauro A, Zanfi C, Ercolani G et al. Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience. Clin Transplant 2007;21:177-85.
64. Middleton SJ, Jamieson NV. The current status of small bowel transplantation in the UK and internationally. Gut 2005;54:1650-7.